Predictive Oncology Inc. (POAI)

NASDAQ: POAI · IEX Real-Time Price · USD
1.124
-0.046 (-3.93%)
Jul 19, 2024, 11:50 AM EDT - Market open
-3.93%
Market Cap 4.59M
Revenue (ttm) 1.96M
Net Income (ttm) -14.78M
Shares Out 4.10M
EPS (ttm) -3.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,418
Open 1.150
Previous Close 1.170
Day's Range 1.124 - 1.167
52-Week Range 0.894 - 6.180
Beta 1.16
Analysts n/a
Price Target n/a
Earnings Date Aug 8, 2024

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvemen... [Read more]

Sector Healthcare
Founded 2002
Employees 35
Stock Exchange NASDAQ
Ticker Symbol POAI
Full Company Profile

Financial Performance

In 2023, POAI's revenue was $1.78 million, an increase of 18.24% compared to the previous year's $1.51 million. Losses were -$13.98 million, -45.67% less than in 2022.

Financial Statements

News

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development

5 weeks ago - GlobeNewsWire

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

Predictive Oncology's organ-specific in vitro models are designed to better mimic  the physiological environment of human tissue

6 weeks ago - GlobeNewsWire

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

Presentation to highlight Company's novel application of AI/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners throu...

7 weeks ago - GlobeNewsWire

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Study successfully demonstrated Predictive's ability to build AI multi-omic machine learning models to predict survival outcomes among ovarian cancer patients better than clinical data alone Study suc...

7 weeks ago - GlobeNewsWire

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

Company to host investor call and webcast today, May 15th, at 8:30am EDT Company to host investor call and webcast today, May 15th, at 8:30am EDT

2 months ago - GlobeNewsWire

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, ext...

2 months ago - GlobeNewsWire

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract has been accepted for prese...

3 months ago - GlobeNewsWire

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Company to host investor call and webcast on Monday, April 1st, at 8:30am EDT Company to host investor call and webcast on Monday, April 1st, at 8:30am EDT

4 months ago - GlobeNewsWire

Predictive Oncology to Participate in Upcoming Investor Conferences

PITTSBURGH, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive Offi...

5 months ago - GlobeNewsWire

Predictive Oncology to Participate in Upcoming San Francisco Conferences

PITTSBURGH, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that Raymond F. Vennare, Chief Executive Offi...

7 months ago - GlobeNewsWire

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

Company to host investor call and webcast today, November 14th, at 8:30am EDT Company to host investor call and webcast today, November 14th, at 8:30am EDT

8 months ago - GlobeNewsWire

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study with...

9 months ago - GlobeNewsWire

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

Company to host investor call and webcast today, August 10th, at 5:30pm EDT Company to host investor call and webcast today, August 10th, at 5:30pm EDT

1 year ago - GlobeNewsWire

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

EAGAN, Minn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, ...

1 year ago - GlobeNewsWire

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

Surrounded by world renowned universities and medical centers, Predictive Oncology is part of the next generation of Pittsburgh's innovation ecosystem

1 year ago - GlobeNewsWire

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

EAGAN, Minn., June 27, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, ...

1 year ago - GlobeNewsWire

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, ...

1 year ago - GlobeNewsWire

Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention

Pamela Bush, Chief Business Officer of Predictive Oncology, to discuss advancing pipelines and using patient heterogeneity with AI to solve the missing link in drug discovery Pamela Bush, Chief Busine...

1 year ago - GlobeNewsWire

Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update

Company to host investor call and webcast today, May 15th, at 5:30pm EDT Company to host investor call and webcast today, May 15th, at 5:30pm EDT

1 year ago - GlobeNewsWire

Predictive Oncology Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023 EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Compan...

1 year ago - GlobeNewsWire

Predictive Oncology Adjourns Special Meeting of Stockholders

MINNEAPOLIS, April 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, exten...

1 year ago - GlobeNewsWire

Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...

1 year ago - GlobeNewsWire

Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy

EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology drug discovery and development, today announces it is part...

1 year ago - GlobeNewsWire

Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update

EAGAN, Minn., March 21, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...

1 year ago - GlobeNewsWire

Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs

EAGAN, Minn., March 17, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) together with Cancer Research Horizons, the innovation engine at the core of the world's largest private funder...

1 year ago - GlobeNewsWire